Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Alert/Advisory (1074)
- Medicine safety (496)
- Medical devices safety (345)
- Safety (61)
- Regulatory compliance (23)
- Prescription medicines (19)
- Import and export (18)
- Listed medicines (16)
- Over the counter (OTC) medicines (14)
- Shortages (14)
- Therapeutic goods regulation (14)
- Complementary medicines (13)
- Australian Register of Therapeutic Goods (ARTG) (12)
- Non-prescription medicines (9)
- Blood safety (8)
- Advertising (5)
- Labelling and packaging (3)
- Sunscreens (3)
- Breast implant hub (2)
- Legislation (2)
- Manufacturing (2)
- Assessed listed medicines (1)
- Compliance and enforcement hub (1)
- Metal-on-metal hip replacement implants hub (1)
- Registered complementary medicines (1)
- Weight loss products (1)
Type of content
Search
1248 result(s) found, displaying 26 to 50
-
Medicine shortage alertsThe supply of Ozempic (semaglutide) will continue to be limited until 31 December 2025
-
Medicine shortage alertsPharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.
-
Market actionsCaruso's Natural Health Pty Ltd is recalling certain batches of WEE LESS, BLOAT EZE and ASHWAGANDHA 7500 due to suspected tampering.
-
Safety alertsGold Max Blue capsules pose a serious risk to your health and should not be taken.
-
Safety alertsDynamint X tablets pose a serious risk to your health and should not be taken.
-
Safety alertsMAXMAN tablets pose a serious risk to your health and should not be taken.
-
Market actionsThere is a potential for insulin leakage with the Accu-Chek Spirit 3.15 ml cartridge system due to a manufacturing problem.
-
Market actionsInsulet is advising they have received complaints of Omnipod DASH PDM/controller battery depletion as a result of the 3G network deactivation in the region.
-
Medicine shortage alertsDue to the concerns and difficulties caused by such shortages, we are giving patients and prescribers early notification so that they can plan ahead.
-
Medicine shortage alertsPharmacists may dispense alternative brands or strengths without a new prescription.
-
Safety alertsThe oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.
-
Safety alertsAfrican Vigorous Max Strength poses a serious risk to your health and should not be taken.
-
Safety alertsWe have tested a further 6 imported, unregistered ivermectin products and found they are counterfeit under the Therapeutic Goods Act 1989.
-
Safety alertsZiyinzhuangyang tablets pose a serious risk to your health and should not be taken.
-
Safety alertsConsumers and health professionals should be aware that counterfeit Ozempic-labelled pens have been imported into Australia. These pens may pose a serious health risk and should not be used. There are clear inconsistencies from the original product to look out for.
-
Safety alertsWe have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.
-
Safety alertsRobust Extreme capsules pose a serious risk to your health and should not be taken.
-
Safety alertsThe TGA has received reports of serious adverse events in infants and children who have been given compounded wind and colic preparations containing Atropa belladonna (belladonna).
-
Safety alertsRead our safety advisory about this ingredient's potential to cause severe allergic reactions including anaphylaxis.
-
Market actionsThe affected bi-level positive airway pressure (BiPAP) devices may stop providing therapy on an intermittent or permanent basis and the ‘Ventilator Inoperative’ alarm will sound.
-
Medicine shortage alertsPharmacists can now substitute one Orencia 125 mg product for the other
-
Safety alertsDark Horse Capsules pose a serious risk to your health and should not be taken.
-
Market actionsIf the dosing syringe is stiff and difficult to use, you may not be able to control the delivery of the medicine. This poses a risk of choking, especially for babies.
-
Market actionsBe alert to the issue of unexpected shut down of the A30 and A40 series bi-level positive airway pressure (BiPAP) devices. This can cause interruptions and loss of therapy for patients.
-
Market actionsBe alert about a higher risk of device failure with the Hintermann Series H3 Total Ankle Replacement (TAR) system. Read this if you're a patient, carer or health care provider.